NEW DELHI: Busy Bee Airways on Friday informed the insolvency appellate tribunal NCLAT that it will try to reach out to the lenders of Go First. Travel portal EaseMyTrip’s co-founder Nishant ...

The National Company Law Appellate Tribunal (NCLAT) on Friday told Busy Bee Airways, a bidder for Go First, to present its acquisition plan before the airline’s lenders. Busy Bee Airways, backed by ...

Musk has told his friends, WIRED reported, that he is too busy to go back home after spending his day at work in the DOGE office based out of the Eisenhower Executive Office Building. Last week, Musk ...

Busy Bee Airways, which has challenged the liquidation of grounded carrier Go First, on Friday informed the insolvency appellate tribunal NCLAT that it will try to reach out to the lenders concerned.

Busy Bee Airways, which has challenged the liquidation of grounded carrier Go First, on Friday informed the insolvency appellate tribunal NCLAT that it will try to reach out to the lenders concerned.

Busy Bee Airways has expressed interest in acquiring the grounded carrier Go First, which is undergoing liquidation proceedings. They plan to reach out to lenders and maintain that Go First's assets ...

Busy Bee Airways, under the leadership of Nishant Pitti, has initiated a bid to prevent the liquidation of Go First, presenting its case before the National Company Law Appellate Tribunal (NCLAT). The ...

The National Company Law Appellate Tribunal (NCLAT) has asked Busy Bee Airways, a bidder for bankrupt airline Go First, to approach the airline’s lenders and negotiate a deal to acquire the ...

Busy Bee Airways aims to acquire Go First as a going concern and will reach out to lenders. NCLAT hears petitions challenging Go First's liquidation. New Delhi, Jan 31 (PTI) Busy Bee Airways, which ...

Tucker, a relatively new figure in indie British filmmaking, makes a distinction with documentary filmmaking because she has just launched her latest feature Garbo: Where Did You Go?, a doc on the ...

Obesity biotech Metsera and renal and metabolic-focused Maze Therapeutics have met their IPO expectations as the two companies prepare to join the Nasdaq this morning. While Metsera is offering ...